Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.

Glassberg MK, Minkiewicz J, Toonkel RL, Simonet ES, Rubio GA, DiFede D, Shafazand S, Khan A, Pujol MV, LaRussa VF, Lancaster LH, Rosen GD, Fishman J, Mageto YN, Mendizabal A, Hare JM.

Chest. 2017 May;151(5):971-981. doi: 10.1016/j.chest.2016.10.061. Epub 2016 Nov 24.

PMID:
27890713
2.

A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease.

Khadawardi H, Mura M.

Respirology. 2017 Apr;22(3):501-507. doi: 10.1111/resp.12945. Epub 2016 Nov 8.

PMID:
27862639
3.

End-of-life care of patients with idiopathic pulmonary fibrosis.

Rajala K, Lehto JT, Saarinen M, Sutinen E, Saarto T, Myllärniemi M.

BMC Palliat Care. 2016 Oct 12;15(1):85.

4.

Ambulatory and short-burst oxygen for interstitial lung disease.

Sharp C, Adamali H, Millar AB.

Cochrane Database Syst Rev. 2016 Jul 6;7:CD011716. doi: 10.1002/14651858.CD011716.pub2. Review.

PMID:
27383922
5.

Cutaneous Metastasis as a First Presentation for Lung Adenocarcinoma.

Abdeen Y, Amireh S, Patel A, Al-Halawani M, Shaaban H, Miller R.

N Am J Med Sci. 2016 May;8(5):222-5. doi: 10.4103/1947-2714.183010.

6.

Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis.

Ley B, Bradford WZ, Vittinghoff E, Weycker D, du Bois RM, Collard HR.

Am J Respir Crit Care Med. 2016 Sep 15;194(6):711-8. doi: 10.1164/rccm.201508-1546OC.

PMID:
26938706
7.

A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis.

Dentice RL, Elkins MR, Middleton PG, Bishop JR, Wark PA, Dorahy DJ, Harmer CJ, Hu H, Bye PT.

Thorax. 2016 Feb;71(2):141-7. doi: 10.1136/thoraxjnl-2014-206716.

PMID:
26769016
8.

The proposed new classification of coronary microcirculation as the predictor of the heart failure progression in idiopathic dilated cardiomyopathy.

Gil KE, Pawlak A, Frontczak-Baniewicz M, Gil RJ, Nasierowska-Guttmejer A.

Cardiovasc Pathol. 2015 Nov-Dec;24(6):351-8. doi: 10.1016/j.carpath.2015.08.001. Epub 2015 Aug 8.

PMID:
26382083
9.

Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis.

Nathan SD, du Bois RM, Albera C, Bradford WZ, Costabel U, Kartashov A, Noble PW, Sahn SA, Valeyre D, Weycker D, King TE Jr.

Respir Med. 2015 Jul;109(7):914-22. doi: 10.1016/j.rmed.2015.04.008. Epub 2015 Apr 24.

10.

Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis.

Vainshelboim B, Oliveira J, Fox BD, Soreck Y, Fruchter O, Kramer MR.

Lung. 2015 Jun;193(3):345-54. doi: 10.1007/s00408-015-9703-0. Epub 2015 Mar 3.

PMID:
25731736
11.

Initial characteristics and outcome of hospitalized patients with amiodarone pulmonary toxicity.

Mankikian J, Favelle O, Guillon A, Guilleminault L, Cormier B, Jonville-Béra AP, Perrotin D, Diot P, Marchand-Adam S.

Respir Med. 2014 Apr;108(4):638-46. doi: 10.1016/j.rmed.2014.01.014. Epub 2014 Feb 10.

12.

Case study. Whose bed? Commentary.

Lipman HI.

Hastings Cent Rep. 2013 Mar-Apr;43(2):14. No abstract available.

PMID:
23599984
13.

Case study. Whose bed? Commentary.

Tong B.

Hastings Cent Rep. 2013 Mar-Apr;43(2):13-4. No abstract available.

PMID:
23599983
14.

Whose bed?

[No authors listed]

Hastings Cent Rep. 2013 Mar-Apr;43(2):13. doi: 10.1002/hast.153. No abstract available.

PMID:
23494697
15.

Role of exercise in testing and in therapy of COPD.

Divo M, Pinto-Plata V.

Med Clin North Am. 2012 Jul;96(4):753-66. doi: 10.1016/j.mcna.2012.05.004. Review.

PMID:
22793943
16.

Silicotuberculosis and silicosis as occupational diseases: report of two cases.

Milovanović A, Nowak D, Milovanović A, Hering KG, Kline JN, Kovalevskiy E, Kundiev YI, Perunicić B, Popević M, Sustran B, Nenadović M.

Srp Arh Celok Lek. 2011 Jul-Aug;139(7-8):536-9.

17.

Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.

Kozu R, Jenkins S, Senjyu H.

Respirology. 2011 Nov;16(8):1196-202. doi: 10.1111/j.1440-1843.2011.02029.x.

PMID:
21810145
18.

Exacerbations in noncystic fibrosis bronchiectasis: Clinical features and investigations.

Kapur N, Masters IB, Chang AB.

Respir Med. 2009 Nov;103(11):1681-7. doi: 10.1016/j.rmed.2009.05.007. Epub 2009 Jun 6.

20.

The clinical course of patients with idiopathic pulmonary fibrosis.

Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr, Flaherty KR, Schwartz DA, Noble PW, Raghu G, Brown KK; IPF Study Group.

Ann Intern Med. 2005 Jun 21;142(12 Pt 1):963-7.

PMID:
15968010

Supplemental Content

Loading ...
Support Center